AQR Capital Management LLC Has $2.50 Million Stock Position in Addus HomeCare Co. (NASDAQ:ADUS)

AQR Capital Management LLC cut its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 41.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 21,507 shares of the company’s stock after selling 15,384 shares during the period. AQR Capital Management LLC owned about 0.12% of Addus HomeCare worth $2,497,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ADUS. Ellsworth Advisors LLC acquired a new position in Addus HomeCare in the 2nd quarter valued at approximately $598,000. Dean Capital Management acquired a new position in Addus HomeCare during the 4th quarter worth about $652,000. Quadrature Capital Ltd bought a new stake in shares of Addus HomeCare in the 1st quarter valued at about $1,557,000. Lord Abbett & CO. LLC acquired a new stake in shares of Addus HomeCare in the first quarter valued at about $8,274,000. Finally, Vanguard Group Inc. raised its position in shares of Addus HomeCare by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock worth $116,753,000 after acquiring an additional 38,876 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $129.02 on Wednesday. The stock has a market capitalization of $2.33 billion, a PE ratio of 32.01, a price-to-earnings-growth ratio of 2.40 and a beta of 1.04. Addus HomeCare Co. has a 52 week low of $78.35 and a 52 week high of $136.12. The stock has a 50 day moving average price of $129.07 and a two-hundred day moving average price of $116.79.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.14. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The business had revenue of $286.90 million during the quarter, compared to the consensus estimate of $284.90 million. During the same quarter last year, the firm posted $0.94 EPS. Addus HomeCare’s revenue was up 10.4% compared to the same quarter last year. Research analysts forecast that Addus HomeCare Co. will post 4.58 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ADUS. TD Cowen increased their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. StockNews.com downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $141.00 price target on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Stephens reissued an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a research report on Tuesday, August 6th. Finally, Macquarie assumed coverage on Addus HomeCare in a research report on Friday, June 28th. They set an “outperform” rating and a $136.00 target price on the stock. One investment analyst has rated the stock with a sell rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and a consensus price target of $128.29.

Insider Transactions at Addus HomeCare

In related news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Esteban Lopez sold 500 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now directly owns 3,366 shares of the company’s stock, valued at approximately $429,165. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 22,917 shares of company stock valued at $3,050,082 over the last three months. Corporate insiders own 4.60% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.